Skip to contentK
Kraig Biocraft Laboratories, Inc.
K
KBLBKraig Biocraft Laboratories, Inc. Q1 2017 · 10-Q
Revenue$0.00$0.00— vs Q1 2016 Net Income-$494.61K-$494.61KN/M vs Q1 2016 EPS Diluted$0.00$0.00— vs Q1 2016 Operating Income-$454,464N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Kraig Biocraft Laboratories, Inc. · CIK 1413119 · Engraved from SEC EDGAR
Free Cash Flowderived-$195,003N/M ended Mar 31, 2017 · filed May 12, 2017 · 42 d after period end